ATS 2025: Real-world cohort study aligns with GSK depemokimab narrative
On 20 May at the American Thoracic Society (ATS) 2025 conference in San Francisco, investigators from the Analysis Group, a …
Post
-
-
WHO secures 20% funding increase amid US shortfall
Member countries of the World Health Organization (WHO) will pay 20% more in membership fees as part of a revamped …
-
ATS 2025: GSK strengthens argument for twice-annual depemokimab
On 20 May 2025 at the American Thoracic Society (ATS) International Conference in San Francisco, a poster presentation by GlaxoSmithKline …
-
BioNTech to invest up to $1.34bn in UK R&D
BioNTech has made a grant agreement with the UK government to expand its research and development (R&D) activities for medicines, …
-
FDA to restrict Covid-19 booster doses to older adults
The US Food and Drug Administration (FDA) is set to restrict Covid-19 booster doses to older adults and those at …
-
HHS sets “most favoured nation” pricing targets for drug makers
The US Department of Health and Human Services (HHS) said it is “taking immediate steps” to implement a recent Executive …
-
China’s mAb and ADC licensing was 3xUS’s in 2024 — will trade tensions slow it?
China’s biopharmaceutical sector saw a rise in oncology drug licensing deals in 2024, particularly for monoclonal antibodies (mAbs) and antibody-drug …
-
ATS 2025: Sanofi and Regeneron to launch new AIM4 trial for personalised asthma care
At the American Thoracic Society (ATS) 2025 Congress on 19 May, Sanofi and Regeneron announced the launch of a new …
-
ATS 2025: ETI-linked mucus clearance tied to lung function gains in paediatric CF
On 19 May, at the 2025 American Thoracic Society (ATS) International Conference, researchers from Cincinnati Children’s Hospital presented compelling evidence …
-
Skye and Arecor to develop higher formulation of CB1 inhibitor
Skye Bioscience has partnered with Arecor Therapeutics to develop a higher formulation of the former’s obesity candidate nimacimab, a cannabinoid receptor …
-
London Biotechnology Show Makes Grand Return to Unveil Cutting-edge Advances in Health & Medicine
The inaugural London Biotechnology Show was a major hit with over 3,000 attendees present at the event, including representatives from …
-
Next‑Gen Pharma: AI, ML & Digital Twins Converge at AUTOMA+ 2025
Big data, Artificial Intelligence (AI), Machine Learning (ML) and other emerging technologies are transforming the pharmaceutical industry right before our …
-
Countries formally adopt WHO’s Pandemic Agreement for future pandemics
After years of debates between governments, member states of the World Health Organization (WHO) have formally adopted the world's first …
-
Japan’s MHLW approves GSK’s Blenrep combos for multiple myeloma
The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted approval for the use of GSK’s Blenrep (belantamab mafodotin) …
-
ATS 2025: Anti–IL-5 therapy cuts exacerbations in coexisting COPD and asthma patients
On 19 May, at the 2025 American Thoracic Society (ATS) International Conference, a poster session by researchers from Ghent University …
